{"schema_version":"secwatch.filing_event.v1","accession":"0001683168-21-002832","form_type":"8-K","ticker":"CNBX","cik":"0001343009","company_name":"CNBX Pharmaceuticals Inc.","filed_at":"2021-07-06T23:59:59+00:00","discovered_at":"2026-05-14T18:04:17.775437+00:00","generated_at":"2026-06-30T07:11:27.972887+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Dr. Inbar Maymon Pomeranchik appointed as independent board member of Cannabics Pharmaceuticals","bullets":["Dr. Inbar Maymon-Pomeranchik, 43, appointed to board effective July 1, 2021.","Holds a PhD in molecular biology from Hebrew University, postdoc from Weizmann Institute, with 20 years exec experience in biotech and global medical cannabis.","Currently serves as founder & CEO of AgChimedes Group, founder of BioDiligence, Executive Director of Ananda Developments, Director of NRGene, and Advisory Board member of Avida Global.","Appointment was unanimously approved by the Board of Directors on July 1, 2021."],"urls":{"canonical":"https://secwatch.observer/filing/0001683168-21-002832","json":"https://secwatch.observer/filing/0001683168-21-002832.json","markdown":"https://secwatch.observer/filing/0001683168-21-002832.md","text":"https://secwatch.observer/filing/0001683168-21-002832.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1343009/000168316821002832/0001683168-21-002832-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1343009/000168316821002832/cannabics_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-30T07:11:27.972887+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"91d0b9ab7c","claim":"Inbar Maymon Pomeranchik was appointed as Independent Board Member at CNBX Pharmaceuticals Inc..","evidence_excerpt":"On July 1 st , 2021, the Board of Directors appointed Dr. Inbar Maymon Pomeranchik as an Independent Board Member.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1343009/000168316821002832/0001683168-21-002832-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Independent Board Member"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}